Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04890288Not ApplicableUnknown

Apneic Intubation Critically Ill Children

Role: collaborator

NCT02500173Terminated

Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy

Role: lead

NCT01039922Recruiting

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

Role: collaborator

NCT03604211Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Role: lead

NCT02998619Completed

Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis

Role: lead

NCT02572362Completed

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

Role: lead

NCT02652000Completed

Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

Role: lead

NCT00854932Not ApplicableUnknown

Neonatal Procalcitonin Intervention Study

Role: collaborator

NCT00898794Unknown

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

Role: lead

NCT00536003Phase 3Terminated

Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor

Role: collaborator

All 10 trials loaded